EntryPoint Capital LLC Has $270,000 Position in Cigna Group $CI

Key Points

• EntryPoint Capital LLC has reduced its stake in Cigna Group by 51.2%, selling 860 shares, leaving it with 820 shares valued at $270,000.
• The company's most recent earnings report revealed an EPS of $7.20, surpassing estimates and highlighting an 11.0% year-over-year revenue growth.
• Cigna Group announced a quarterly dividend of $1.51 per share, with a dividend yield of 2.0%, set to be paid on September 18th.

EntryPoint Capital LLC reduced its position in Cigna Group (NYSE:CI - Free Report) by 51.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 820 shares of the health services provider's stock after selling 860 shares during the quarter. EntryPoint Capital LLC's holdings in Cigna Group were worth $270,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of CI. Nuveen LLC bought a new position in Cigna Group in the 1st quarter valued at about $727,905,000. GAMMA Investing LLC grew its holdings in shares of Cigna Group by 58,799.0% during the 1st quarter. GAMMA Investing LLC now owns 1,774,626 shares of the health services provider's stock valued at $583,852,000 after purchasing an additional 1,771,613 shares during the last quarter. GQG Partners LLC grew its holdings in shares of Cigna Group by 21.5% during the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider's stock valued at $1,607,716,000 after purchasing an additional 865,092 shares during the last quarter. Two Sigma Advisers LP grew its holdings in shares of Cigna Group by 278.0% during the 4th quarter. Two Sigma Advisers LP now owns 816,200 shares of the health services provider's stock valued at $225,385,000 after purchasing an additional 600,300 shares during the last quarter. Finally, Voloridge Investment Management LLC grew its holdings in shares of Cigna Group by 400.9% during the 4th quarter. Voloridge Investment Management LLC now owns 643,253 shares of the health services provider's stock valued at $177,628,000 after purchasing an additional 514,841 shares during the last quarter. 86.99% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

CI has been the topic of several research reports. Wells Fargo & Company decreased their price target on shares of Cigna Group from $341.00 to $340.00 and set an "equal weight" rating on the stock in a report on Thursday, August 14th. Guggenheim reaffirmed a "buy" rating and set a $350.00 price target (down from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Barclays decreased their price target on shares of Cigna Group from $385.00 to $354.00 and set an "overweight" rating on the stock in a report on Friday, August 1st. Truist Financial lifted their price target on shares of Cigna Group from $385.00 to $405.00 and gave the company a "buy" rating in a report on Monday, May 12th. Finally, Wall Street Zen lowered shares of Cigna Group from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of "Buy" and a consensus target price of $374.82.

Insider Activity

In other news, insider Nicole S. Jones sold 28,526 shares of the business's stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.70% of the company's stock.

Cigna Group Trading Down 0.1%

Shares of NYSE CI traded down $0.38 during midday trading on Tuesday, reaching $300.38. The stock had a trading volume of 2,487,036 shares, compared to its average volume of 1,846,777. The firm has a market cap of $80.18 billion, a price-to-earnings ratio of 16.40, a price-to-earnings-growth ratio of 0.89 and a beta of 0.47. Cigna Group has a twelve month low of $256.89 and a twelve month high of $370.83. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The company's 50 day moving average price is $300.64 and its 200 day moving average price is $311.79.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.15 by $0.05. The firm had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company's revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, sell-side analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be given a $1.51 dividend. The ex-dividend date is Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. Cigna Group's payout ratio is 32.97%.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.